News + Filings Holdings
All 13F 13D/G Other
|
EVENTIDE ASSET MANAGEMENT, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Vital Farms, Inc. |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Sutro Biopharma, Inc. |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Essa Pharma Inc. |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Zymeworks Inc. |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.4% stake in VectivBio Holding AG |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 2.2% stake in Prometheus Biosciences, Inc. |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.1% stake in Freeline Therapeutics Holdings plc |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 3.7% stake in Cogent Biosciences, Inc. |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.6% stake in Annexon, Inc. |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.5% stake in Praxis Precision Medicines, Inc. |
02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in KnowBe4, Inc. |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.6% stake in Collegium Pharmaceutical, Inc. |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.3% stake in Vital Farms, Inc. |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.9% stake in Sutro Biopharma, Inc. |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 8.5% stake in Praxis Precision Medicines, Inc. |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0.6% stake in KalVista Pharmaceuticals, Inc. |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Kala Pharmaceuticals, Inc. |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.7% stake in Freeline Therapeutics Holdings plc |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.5% stake in ESSA Pharma Inc. |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 1.2% stake in Entasis Therapeutics Holdings, Inc. |
02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.4% stake in Annexon, Inc. |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/04/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/04/2020 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 8.7% stake in Magenta Therapeutics, Inc. |
02/04/2020 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.4% stake in KalVista Pharmaceuticals, Inc. |
02/04/2020 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.7% stake in Essa Pharma Inc. |
02/04/2020 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.2% stake in Collegium Pharmaceutical, Inc. |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|